Schonfeld Strategic Advisors LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1665241 NEW YORK, NY

Position in JAZZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,747,945

-$11,918,945 QoQ

Shares Held

62,142

-55.4% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. JAZZ ranks #6 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc This page	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,747,945	62,142	-55.4%	Shares	Sole	2026-05-15
2025-12-31	$23,666,890	139,217	-68.1%	Shares	Sole	2026-02-17
2025-09-30	$57,523,187	436,443	+592.1%	Shares	Sole	2025-11-14
2025-06-30	$6,691,927	63,060	+132.1%	Shares	Sole	2025-08-14
2025-03-31	$3,373,155	27,170	-7.3%	Shares	Sole	2025-05-15
2024-12-31	$3,610,388	29,317	-69.1%	Shares	Sole	2025-02-14
2024-09-30	$10,567,238	94,850	+2100.2%	Shares	Sole	2024-11-14
2023-12-31	$530,253	4,311	-79.6%	Shares	Sole	2024-02-14
2022-06-30	$3,291,654	21,099	+2.8%	Shares	Sole	2022-08-15
2021-03-31	$3,374,680	20,531	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.